Ensign Peak Advisors
THC icon

Ensign Peak Advisors’s Tenet Healthcare THC Stock Holding History

Ensign Peak Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28M Buy
33,548
+28,171
+524% +$5.18M 0.01% 525
2026
Q1 		$1.01M Buy
5,377
+400
+8% +$84.3K ﹤0.01% 832
2025
Q4 		$989K Sell
4,977
-10,300
-67% -$2.08M ﹤0.01% 820
2025
Q3 		$3.1M Sell
15,277
-11,300
-43% -$2M 0.01% 698
2025
Q2 		$4.68M Sell
26,577
-5,250
-16% -$790K 0.01% 663
2025
Q1 		$4.28M Hold
31,827
– – 0.01% 669
2024
Q4 		$4.02M Hold
31,827
– – 0.01% 704
2024
Q3 		$5.29M Hold
31,827
– – 0.01% 609
2024
Q2 		$4.23M Sell
31,827
-2,740
-8% -$330K 0.01% 665
2024
Q1 		$3.63M Buy
34,567
+1,134
+3% +$102K 0.01% 727
2023
Q4 		$2.53M Hold
33,433
– – 0.01% 821
2023
Q3 		$2.2M Hold
33,433
– – ﹤0.01% 805
2023
Q2 		$2.72M Sell
33,433
-3,800
-10% -$271K 0.01% 769
2023
Q1 		$2.21M Sell
37,233
-870
-2% -$48.4K ﹤0.01% 812
2022
Q4 		$1.86M Sell
38,103
-1,370
-3% -$63.3K ﹤0.01% 841
2022
Q3 		$2.04M Buy
39,473
+1,020
+3% +$60.5K 0.01% 774
2022
Q2 		$2.02M Buy
38,453
+5,655
+17% +$394K ﹤0.01% 796
2022
Q1 		$2.82M Sell
32,798
-5,690
-15% -$467K 0.01% 756
2021
Q4 		$3.14M Sell
38,488
-48,185
-56% -$3.52M 0.01% 810
2021
Q3 		$5.76M Buy
86,673
+2,100
+2% +$149K 0.01% 600
2021
Q2 		$5.67M Hold
84,573
– – 0.01% 605
2021
Q1 		$4.4M Hold
84,573
– – 0.01% 684
2020
Q4 		$3.38M Hold
84,573
– – 0.01% 774
2020
Q3 		$2.07M Hold
84,573
– – 0.01% 954
2020
Q2 		$1.53M Hold
84,573
– – ﹤0.01% 1105
2020
Q1 		$1.22M Buy
84,573
+5,300
+7% +$152K ﹤0.01% 1084
2019
Q4 		$3.02M Buy
+79,273
New +$2.37M 0.01% 848

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ensign Peak Advisors's THC Position: Q2 2026 in Review

Ensign Peak Advisors increased its Tenet Healthcare (THC) stake by 524% in Q2 2026, buying an estimated $5.18M and bringing the position to 33,548 shares worth $6.28M. The position accounts for 0.01% of the portfolio, ranked #525.

Ensign Peak Advisors first reported a position in THC in Q4 2019 and has held it in 27 quarters since. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Ensign Peak Advisors held 33,548 shares of Tenet Healthcare worth $6.28M as of Q2 2026.
  • Ensign Peak Advisors bought 28,171 Tenet Healthcare shares in Q2 2026, an estimated $5.18M.
  • Tenet Healthcare made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #525 holding.
  • Ensign Peak Advisors first reported a position in Tenet Healthcare in Q4 2019 and has held it in 27 quarters since.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.